Record Information |
---|
Version | 2.0 |
---|
Created at | 2005-11-16 15:48:42 UTC |
---|
Updated at | 2022-01-25 19:39:37 UTC |
---|
NP-MRD ID | NP0000332 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Alpha-Lactose |
---|
Description | Alpha-Lactose is the major sugar present in milk and the main source of energy supplied to the newborn mammalian in its mother's milk. Lactose is also an important osmotic regulator of lactation. It is digested by the intestinal lactase (EC 3.2.1.108), An enzyme expressed in newborns. Its activity declines following weaning. As a result, adult mammals are normally lactose-intolerant and more than 75% of the human adult population suffers from lactase deficiency. Lactase deficiency is present in up to 80 percent of blacks and Latinos, and up to 100 percent of American Indians and Asians. Persons with lactose intolerance are unable to digest significant amounts of lactose. Common symptoms include abdominal pain and bloating, excessive flatus, and watery stool following the ingestion of foods containing lactose. A sizable number of adults believe they are lactose intolerant but do not actually have impaired lactose digestion, and some persons with lactase deficiency can tolerate moderate amounts of ingested lactose. A diagnosis of lactose intolerance can usually be made with a careful history supported by dietary manipulation. If necessary, diagnosis can be confirmed by using a breath hydrogen or lactose tolerance test. These mostly uncomfortable symptoms of lactose maldigestion are blamed for a variably dairy consumption. There is, however, emerging evidence that certain lactic acid-producing bacteria, which selectively consume prebiotics, may be beneficial against some lower intestinal diseases. Lactose maldigestion and lactose should perhaps be re-evaluated as a potential provider of such a prebiotic. Treatment consists primarily of avoiding lactose-containing foods. Lactase enzyme supplements may be helpful. The degree of lactose malabsorption varies greatly among patients with lactose intolerance, but most of them can ingest up to 350 mL of milk daily without symptoms. Lactose-intolerant patients must ensure adequate calcium intake. (PMID: 13130292 , 12216958 , 12197838 , 12018807 ). Lactose in the urine is a biomarker for the consumption of milk. |
---|
Structure | OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O InChI=1S/C12H22O11/c13-1-3-5(15)6(16)9(19)12(22-3)23-10-4(2-14)21-11(20)8(18)7(10)17/h3-20H,1-2H2/t3-,4-,5+,6+,7-,8-,9-,10-,11+,12+/m1/s1 |
---|
Synonyms | Value | Source |
---|
1-beta-D-Galactopyranosyl-4-alpha-D-glucopyranose | ChEBI | 4-O-beta-D-Galactopyranosyl-alpha-D-glucopyranose | ChEBI | Anhydrous lactose | ChEBI | beta-D-Galp-(1->4)-alpha-D-GLCP | ChEBI | Lactose | ChEBI | Milk sugar | ChEBI | WURCS=2.0/2,2,1/[a2122h-1a_1-5][a2112h-1b_1-5]/1-2/a4-b1 | ChEBI | 1-b-D-Galactopyranosyl-4-a-D-glucopyranose | Generator | 1-Β-D-galactopyranosyl-4-α-D-glucopyranose | Generator | 4-O-b-D-Galactopyranosyl-a-D-glucopyranose | Generator | 4-O-Β-D-galactopyranosyl-α-D-glucopyranose | Generator | b-D-Galp-(1->4)-a-D-GLCP | Generator | Β-D-galp-(1->4)-α-D-GLCP | Generator | a-Lactose | Generator | Α-lactose | Generator | (+)-Lactose | HMDB | 1-beta-delta-Galactopyranosyl-4-alpha-delta-glucopyranose | HMDB | 4-O-Hexopyranosylhexose | HMDB | Aletobiose | HMDB | Dilactose | HMDB | Fast-flo lactose | HMDB | Flowlac 100 | HMDB | Galactinum | HMDB | GLC-(4-1)Gal | HMDB | Granulac 140m | HMDB | Lactin | HMDB | Lactin (carbohydrate) | HMDB | Lactobiose | HMDB | Lactohale 300 | HMDB | Lactose anhydride | HMDB | Lactose fast-flo | HMDB | Osmolactan | HMDB | Pharmatosa DCL 21 | HMDB | Pharmatose 21 | HMDB | Pharmatose 325m | HMDB | Pharmatose DCL 15 | HMDB | Prismalac | HMDB | Respitose ML 003 | HMDB | Respitose SV 003 | HMDB | Saccharum lactin | HMDB | Sachelac | HMDB | Sorbalac 400 | HMDB | Sorbolac 400 | HMDB | Spherolac | HMDB | Super-tab | HMDB | Tablettose | HMDB | Tablettose 70 | HMDB | Tablettose 80 | HMDB | Zeparox ep | HMDB | Lactose, anhydrous | HMDB |
|
---|
Chemical Formula | C12H22O11 |
---|
Average Mass | 342.2965 Da |
---|
Monoisotopic Mass | 342.11621 Da |
---|
IUPAC Name | (2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-{[(2R,3S,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxane-3,4,5-triol |
---|
Traditional Name | α-lactose |
---|
CAS Registry Number | 63-42-3 |
---|
SMILES | OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O |
---|
InChI Identifier | InChI=1S/C12H22O11/c13-1-3-5(15)6(16)9(19)12(22-3)23-10-4(2-14)21-11(20)8(18)7(10)17/h3-20H,1-2H2/t3-,4-,5+,6+,7-,8-,9-,10-,11+,12+/m1/s1 |
---|
InChI Key | GUBGYTABKSRVRQ-XLOQQCSPSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, simulated) | Ahselim | | | 2022-02-02 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 400 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 400 MHz, H2O, simulated) | v.dorna83@yahoo.com | Not Available | Not Available | 2021-08-08 | View Spectrum |
| Species |
---|
Species of Origin | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as o-glycosyl compounds. These are glycoside in which a sugar group is bonded through one carbon to another group via a O-glycosidic bond. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic oxygen compounds |
---|
Class | Organooxygen compounds |
---|
Sub Class | Carbohydrates and carbohydrate conjugates |
---|
Direct Parent | O-glycosyl compounds |
---|
Alternative Parents | |
---|
Substituents | - O-glycosyl compound
- Disaccharide
- Oxane
- Secondary alcohol
- Hemiacetal
- Oxacycle
- Organoheterocyclic compound
- Polyol
- Acetal
- Hydrocarbon derivative
- Primary alcohol
- Alcohol
- Aliphatic heteromonocyclic compound
|
---|
Molecular Framework | Aliphatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | 201 - 202 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 195 mg/mL at 20 °C | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Jung SK, Fujimoto D: A novel beta-galactoside-binding lectin in adult rat kidney. J Biochem. 1994 Sep;116(3):547-53. [PubMed:7852273 ]
- Oozeer R, Furet JP, Goupil-Feuillerat N, Anba J, Mengaud J, Corthier G: Differential activities of four Lactobacillus casei promoters during bacterial transit through the gastrointestinal tracts of human-microbiota-associated mice. Appl Environ Microbiol. 2005 Mar;71(3):1356-63. [PubMed:15746338 ]
- Dimopoulos MA, Anagnostopoulos A: Thalidomide in relapsed/refractory multiple myeloma: pivotal trials conducted outside the United States. Semin Hematol. 2003 Oct;40(4 Suppl 4):8-16. [PubMed:15015891 ]
- Muthusamy A, Erickson DR, Sheykhnazari M, Bhavanandan VP: Enhanced binding of modified pentosan polysulfate and heparin to bladder--a strategy for improved treatment of interstitial cystitis. Urology. 2006 Jan;67(1):209-13. [PubMed:16413377 ]
- Johnson JD, Simoons FJ, Hurwitz R, Grange A, Mitchell CH, Sinatra FR, Sunshine P, Robertson WV, Bennett PH, Kretchmer N: Lactose malabsorption among the Pima indians of Arizona. Gastroenterology. 1977 Dec;73(6):1299-304. [PubMed:578795 ]
- Lustenberger RW: [A 23-year old patient with chronic diarrhea. Celiac disease and lactose intolerance]. Praxis (Bern 1994). 2005 Feb 2;94(5):163-4. [PubMed:15745382 ]
- Sharma A, DiCioccio RA, Allen HJ: Identification and synthesis of a novel 15 kDa beta-galactoside-binding lectin in human leukocytes. Glycobiology. 1992 Aug;2(4):285-92. [PubMed:1421750 ]
- Rana SV, Bhasin DK, Vinayak VK: Lactose hydrogen breath test in Giardia lamblia-positive patients. Dig Dis Sci. 2005 Feb;50(2):259-61. [PubMed:15745082 ]
- Mitchell JD, Brand J, Halbisch J: Weight-gain inhibition by lactose in Australian Aboriginal children. A controlled trial of normal and lactose hydrolysed milk. Lancet. 1977 Mar 5;1(8010):500-2. [PubMed:65606 ]
- Soupene E, van Heeswijk WC, Plumbridge J, Stewart V, Bertenthal D, Lee H, Prasad G, Paliy O, Charernnoppakul P, Kustu S: Physiological studies of Escherichia coli strain MG1655: growth defects and apparent cross-regulation of gene expression. J Bacteriol. 2003 Sep;185(18):5611-26. [PubMed:12949114 ]
- Yeoh E, Horowitz M, Russo A, Muecke T, Robb T, Chatterton B: The effects of abdominal irradiation for seminoma of the testis on gastrointestinal function. J Gastroenterol Hepatol. 1995 Mar-Apr;10(2):125-30. [PubMed:7787155 ]
- Bondesson E, Bengtsson T, Borgstrom L, Nilsson LE, Norrgren K, Olsson B, Svensson M, Wollmer P: Dose delivery late in the breath can increase dry powder aerosol penetration into the lungs. J Aerosol Med. 2005 Spring;18(1):23-33. [PubMed:15741771 ]
- Roberson CM: Lactose intolerance. Ala Nurse. 2004 Dec-2005 Feb;31(4):23-4; quiz 24. [PubMed:15662762 ]
- Kim KI, Lee WS, Benevenga NJ: Feeding diets containing high levels of milk products or cellulose decrease urease activity and ammonia production in rat intestine. J Nutr. 1998 Jul;128(7):1186-91. [PubMed:9649604 ]
- Gunther S, Patterson RE, Kristal AR, Stratton KL, White E: Demographic and health-related correlates of herbal and specialty supplement use. J Am Diet Assoc. 2004 Jan;104(1):27-34. [PubMed:14702580 ]
- Delaveau P: [Milk lactose. Hypothesis on its biological importance]. Ann Pharm Fr. 2003;61(5):340-2. [PubMed:13130292 ]
- Vilotte JL: Lowering the milk lactose content in vivo: potential interests, strategies and physiological consequences. Reprod Nutr Dev. 2002 Mar-Apr;42(2):127-32. [PubMed:12216958 ]
- Szilagyi A: Review article: lactose--a potential prebiotic. Aliment Pharmacol Ther. 2002 Sep;16(9):1591-602. [PubMed:12197838 ]
- Swagerty DL Jr, Walling AD, Klein RM: Lactose intolerance. Am Fam Physician. 2002 May 1;65(9):1845-50. [PubMed:12018807 ]
- Nizic Nodilo L, Ugrina I, Spoljaric D, Amidzic Klaric D, Jakobusic Brala C, Perkusic M, Pepic I, Lovric J, Sarson V, Safundzic Kucuk M, Zadravec D, Kalogjera L, Hafner A: A Dry Powder Platform for Nose-to-Brain Delivery of Dexamethasone: Formulation Development and Nasal Deposition Studies. Pharmaceutics. 2021 May 26;13(6). pii: pharmaceutics13060795. doi: 10.3390/pharmaceutics13060795. [PubMed:34073500 ]
|
---|